No matter how much she ate, she never felt satisfied. But after starting a non-FDA approved GLP-1 agonist—an injectable drug similar to the diabetes drug Ozempic and the weight-loss drug Wegovy—last ...

Popular weight-loss drugs are helping some runners lose weight and crush PRs. Experts have some real concerns.

Lexaria's strategy is to continue developing and optimizing our wholly-owned DehydraTECH™ drug delivery platform for application in the GLP-1 space, positioning it as a 'must-have' technology for ...

End of Period Subscribers of 3.7 millionRevenues of $192.9 millionGross margin of 67.1%; adjusted gross margin of 69.1%Operating Loss of $39.0 million; adjusted operating income of $35.7 million NEW ...

“Wearable activity trackers can support healthy lifestyle behaviour change through goal setting, personalized coaching or ...

Are you a tea lover? Which tea variety do you prefer? If you want to lose weight, black tea might be a great pick. Learn how black tea helps with weight loss and offers other benefits. Did you know ...

A new study reveals that among privately insured patients with obesity, weight loss drug use has more than doubled and ...

With 2024 reports warning that obesity remains an ominous health threat across America, the avoidable condition is plaguing almost half (42.7%) of the U.S. population. This scary statistic is that ...

With the new-look Big Ten officially in effect, Penn State is scheduled to play at Ohio State in 2025 but won’t play the Buckeyes in 2026 and 2027. The conference powers and rivals won’t do battle in ...

Obesity, a rapidly growing health issue in India and around the world, affects men, women, and children from all levels of a ...

The demand for bariatric operations dropped sharply last year as use of anti-obesity drugs such as Wegovy surged, study finds ...

"Anecdotally, health systems have closed hospital-based metabolic bariatric surgery programs due to decreased demand," they ...